Loxapine succinate: a controlled double-blind study in schizophrenia.
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013888:Thiothixene / Q000627:therapeutic use; D013997:Time Factors
D003989:Dibenzoxazepines; D010879:Piperazines; D010919:Placebos; D013888:Thiothixene